News | November 12, 2021
Solara Active Pharma Sciences PAT slides to Rs 29.71 cr in Q2FY22
Solara Active Pharma Sciences has reported consolidated financial results for the period ended September 30, 2021.
Solara Active Pharma Sciences has reported consolidated financial results for the period ended September 30, 2021.
This approval of shelf-life extension was based on the availability of additional stability data, which was submitted to CDSCO
This is the eighth Covid-19 vaccine to receive Emergency Use Listing
FDI increased 98% year on year in 2020 and pharma exports grew by 18% in the last financial year
The WHO chief scientist Soumya Swaminathan tweeted on Oct. 17
This is a virtual event and the theme is `Transforming Healthcare beyond Covid’
_256_384.jpg)
The two doses of Covaxin are likely to be administered to children with a gap of 28 days
Bharat Biotech has been submitting data to the WHO on a rolling basis and submitted additional information at WHO’s request on September 27th 2021
More than 90,000 patients utilise the services daily
These modules will act as a guide to doctors and health care workers to deal with post-Covid-19 issues
Subscribe To Our Newsletter & Stay Updated
